These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
711 related items for PubMed ID: 19782716
1. Antivenom efficacy or effectiveness: the Australian experience. Isbister GK. Toxicology; 2010 Feb 09; 268(3):148-54. PubMed ID: 19782716 [Abstract] [Full Text] [Related]
2. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Isbister GK, O'Leary MA, Schneider JJ, Brown SG, Currie BJ, ASP Investigators. Toxicon; 2007 Jan 09; 49(1):57-67. PubMed ID: 17055016 [Abstract] [Full Text] [Related]
3. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits. Sutherland SK. Med J Aust; 2007 Jan 09; 157(11-12):734-9. PubMed ID: 1360618 [Abstract] [Full Text] [Related]
4. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Johnston CI, Brown SG, O'Leary MA, Currie BJ, Greenberg R, Taylor M, Barnes C, White J, Isbister GK, ASP investigators. Clin Toxicol (Phila); 2013 Jun 09; 51(5):417-24. PubMed ID: 23586640 [Abstract] [Full Text] [Related]
6. An examination of the activity of expired and mistreated commercial Australian antivenoms. O'Leary MA, Kornhauser RS, Hodgson WC, Isbister GK. Trans R Soc Trop Med Hyg; 2009 Sep 09; 103(9):937-42. PubMed ID: 19144367 [Abstract] [Full Text] [Related]
8. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF. Toxicon; 2010 Aug 01; 56(1):75-85. PubMed ID: 20338189 [Abstract] [Full Text] [Related]
9. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25). Johnston CI, Ryan NM, O'Leary MA, Brown SG, Isbister GK. Clin Toxicol (Phila); 2017 Feb 01; 55(2):115-122. PubMed ID: 27903075 [Abstract] [Full Text] [Related]
11. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures? O'Leary MA, Schneider JJ, Krishnan BP, Lavis C, McKendry A, Ong LK, Isbister GK. Toxicon; 2007 Aug 01; 50(2):206-13. PubMed ID: 17467763 [Abstract] [Full Text] [Related]
12. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. Maduwage K, Isbister GK. PLoS Negl Trop Dis; 2014 Oct 01; 8(10):e3220. PubMed ID: 25340841 [Abstract] [Full Text] [Related]
13. The Australian mulga snake (Pseudechis australis: Elapidae): report of a large case series of bites and review of current knowledge. Razavi S, Weinstein SA, Bates DJ, Alfred S, White J. Toxicon; 2014 Jul 01; 85():17-26. PubMed ID: 24726467 [Abstract] [Full Text] [Related]